{
    "organizations": [],
    "uuid": "206f711a208e413535ad70a84a983530a3852227",
    "author": "",
    "url": "https://www.reuters.com/article/brief-teva-pharm-ceo-cfo-comments-on-201/brief-teva-pharm-ceo-cfo-comments-on-2018-outlook-idUSJ7N1NL005",
    "ord_in_thread": 0,
    "title": "BRIEF-Teva Pharm CEO, CFO comments on 2018 outlook",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 8, 2018 / 2:02 PM / in 14 minutes BRIEF-Teva Pharm CEO, CFO comments on 2018 outlook Reuters Staff 1 Min Read \nFeb 8 (Reuters) - Teva Pharmaceutical Industries Ltd : \n* TEVA CEO SCHULTZ: HALF OF EXPECTED REVENUE DECLINE IN 2018 DUE TO GENERIC COMPETITION TO COPAXONE \n* TEVA CEO SCHULTZ: OPTIMISTIC TEVA WILL CONTINUE TO REDUCE ITS DEBT LEVELS \n* TEVA CEO SCHULTZ: TEVA REDUCED DEBT BY $1.1 BILLION SINCE END OF 2017 \n* TEVA CFO: COPAXONE SALES ESTIMATED AT $1.8 BILLION IN 2018 \n* TEVA CFO SEES GENERIC PROAIR COMPETITION IN SECOND HALF OF 2018 \n* TEVA CFO SEES SECOND GENERIC 40 MG COPAXONE AS EARLY AS APRIL * TEVA CFO: GROSS DEBT TO FALL BY $3.5 BILLION IN 2018 \n* TEVA CEO: TEVA WILL NO LONGER GIVE SPECIFIC NUMBERS ON PRICE EROSION \n* TEVA CFO: MAY LOOK FOR FURTHER ASSET DIVESTMENTS IN 2018 TO PAY DOWN DEBT Further company coverage: (Reporting by Steven Scheer)",
    "published": "2018-02-08T16:01:00.000+02:00",
    "crawled": "2018-02-08T16:20:55.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "minute",
        "pharm",
        "ceo",
        "cfo",
        "comment",
        "outlook",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "teva",
        "pharmaceutical",
        "industry",
        "ltd",
        "teva",
        "ceo",
        "schultz",
        "half",
        "expected",
        "revenue",
        "decline",
        "due",
        "generic",
        "competition",
        "copaxone",
        "teva",
        "ceo",
        "schultz",
        "optimistic",
        "teva",
        "continue",
        "reduce",
        "debt",
        "level",
        "teva",
        "ceo",
        "schultz",
        "teva",
        "reduced",
        "debt",
        "billion",
        "since",
        "end",
        "teva",
        "cfo",
        "copaxone",
        "sale",
        "estimated",
        "billion",
        "teva",
        "cfo",
        "see",
        "generic",
        "proair",
        "competition",
        "second",
        "half",
        "teva",
        "cfo",
        "see",
        "second",
        "generic",
        "mg",
        "copaxone",
        "early",
        "april",
        "teva",
        "cfo",
        "gross",
        "debt",
        "fall",
        "billion",
        "teva",
        "ceo",
        "teva",
        "longer",
        "give",
        "specific",
        "number",
        "price",
        "erosion",
        "teva",
        "cfo",
        "may",
        "look",
        "asset",
        "divestments",
        "pay",
        "debt",
        "company",
        "coverage",
        "reporting",
        "steven",
        "scheer"
    ]
}